Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Karuna Therapeutics (KRTX) stocks in Canada

Learn how to easily invest in Karuna Therapeutics stocks.

Karuna Therapeutics is a biotechnology business based in the US. Karuna Therapeutics stocks (KRTX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $120.04 – a decrease of 0.6% over the previous week. Karuna Therapeutics employs 63 staff and has a market cap (total outstanding stock value) of $3.4 billion.

How to buy shares in Karuna Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KRTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Karuna Therapeutics stock price (NASDAQ:KRTX)

Use our graph to track the performance of KRTX stocks over time.

Karuna Therapeutics shares at a glance

Information last updated 2022-01-24.
Latest market close$112.00
52-week range$94.90 - $161.98
50-day moving average $125.24
200-day moving average $120.64
Wall St. target price$175.07
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.92

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Karuna Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Karuna Therapeutics price performance over time

Historical closes compared with the close of $112 from 2022-01-25

1 week (2022-01-20) 0.22%
1 month (2021-12-23) -16.12%
3 months (2021-10-27) -16.41%
6 months (2021-07-27) 0.83%
1 year (2021-01-27) 17.33%
2 years (2020-01-24) 12.28%
3 years (2019-01-23) N/A
5 years (2017-01-23) N/A

Karuna Therapeutics financials

Gross profit TTM $0
Return on assets TTM -19.06%
Return on equity TTM -31.95%
Profit margin 0%
Book value $17.51
Market capitalisation $3.4 billion

TTM: trailing 12 months

Karuna Therapeutics share dividends

We're not expecting Karuna Therapeutics to pay a dividend over the next 12 months.

Karuna Therapeutics share price volatility

Over the last 12 months, Karuna Therapeutics's shares have ranged in value from as little as $94.9 up to $161.98. A popular way to gauge a stock's volatility is its "beta".

KRTX.US volatility(beta: 1.72)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Karuna Therapeutics's is 1.7212. This would suggest that Karuna Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Karuna Therapeutics overview

Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that has completed Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia; and in Phase Ib clinical trial for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc.

Stocks similar to Karuna Therapeutics

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

COVID testing stocks

COVID testing stocks

We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.

Read more…
TQQQ vs. QQQ

TQQQ vs. QQQ

Review the benefits and risks of investing in these tech-focused ETFs.

Read more…
How to buy Canadian blue chip stocks

How to buy Canadian blue chip stocks

Read more…

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site